Save up to 10% today

Tirzepatide

10mg >99% purity Coa verified

CA$58.00

Tirzepatide is a synthetic dual agonist peptide that targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It has been studied in clinical and preclinical research for its roles in metabolic signaling, glucose regulation, and endocrine pathway modulation. Tirzepatide is also investigated for its involvement in energy balance and hormone-mediated signaling processes. A widely studied compound in metabolic and peptide research.

>99% Purity · Third-Party Tested · For Research Use Only. All products currently listed on this site are for research purposes only.

Matrix Peptides

FDA Disclaimer

All products sold by Matrix Peptides are intended strictly for laboratory research and development purposes only. These products are not intended for human consumption, injection, or diagnostic use.

The statements made on this website have not been evaluated by Health Canada or the U.S. Food and Drug Administration (FDA). The products offered are not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Matrix Peptides operates as a chemical supplier. We are not a licensed pharmacy, compounding pharmacy, or outsourcing facility as defined under applicable Canadian or United States regulations.

All products are intended for in-vitro and pre-clinical research use only. By purchasing from this website, the customer represents and warrants that

They are a qualified professional or researcher
They understand the nature of the products
They will use the products in compliance with all applicable laws and regulations
They have the proper training, facilities, and safety protocols in place

The customer acknowledges that there are inherent risks associated with the handling and use of research chemicals, and agrees that Matrix Peptides shall not be held liable for any misuse, improper handling, or use outside of intended research purposes.

Contact

Matrixpeps@gmail.com